CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Sergey Kasparov

ORCID: 0000-0002-1824-1764↗

Public evidence

1 connected articles

Long term administration of selective NMDA GluN2B receptor blocker Ro25-6981 attenuates neurodegeneration in mouse model of spinocerebellar ataxia type 1 (SCA1).2026 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Sergey Kasparov - Medical Cannabis Research Engine